SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
-------------
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR 12(g) OF THE
SECURITIES EXCHANGE ACT OF 1934
Schein Pharmaceutical, Inc.
(Exact Name of Registrant as Specified in Its Charter)
Delaware 11-2726505
(State of Incorporation or Organization) (I.R.S. Employer
Identification no.)
100 Campus Drive, 07932
Florham Park, New Jersey (Zip Code)
(Address of Principal Executive Offices)
If this form relates to the If this form relates to the
registration of a class of debt registration of a class of
securities and is effective debt securities and is to
upon filing pursuant to General the effectiveness of a
Instruction A(c)(1) please concurrent registration
check the following box. [] statement under the Securities
Act of 1933 pursuant to
General Instruction A(c)(2)
please check the following
box. []
Securities to be registered pursuant to Section 12(b) of the Act:
Title of Each Class Name of Each Exchange on Which
to be so Registered Each Class is to be Registered
Common Stock, par value New York Stock Exchange
$.01 per share
Securities to be registered pursuant to Section 12(g) of the Act:
Item 1. Description of Registrant's Securities to be
Registered.
See "Description of Capital Stock" in the Company's
Registration Statement on Form S-1 (Registration No. 333-
41413) (the "Form S-1") filed with the Securities and
Exchange Commission, which information is hereby
incorporated herein by reference.
Item 2. Exhibits.
Not applicable.
SIGNATURE
Pursuant to the requirements of Section 12 of the
Securities Exchange Act of 1934, the registrant has duly caused
this registration statement to be signed on its behalf by the
undersigned, thereto duly authorized.
Schein Pharmaceutical, Inc.
(Registrant)
Date: April 3, 1998 By: /s/ Martin Sperber
Name: Martin Sperber
Title: Chairman and Chief
Executive Officer
